NOVAVAX INC (NVAX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $15.79M2011: $12.73M2012: $22.11M2013: $31.89M2014: $46.38M2015: $93.37M2016: $399.85M2017: $404.23M2018: $375.91M2019: $358.97M2020: $955.27M2021: $2.93B2022: $2.89B2023: $2.51B2024: $2.18B2025: $1.30B$1.30B
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.30B-40.3%
2024$2.18B-13.1%
2023$2.51B-13.1%
2022$2.89B-1.2%
2021$2.93B+206.6%
2020$955.27M+166.1%
2019$358.97M-4.5%
2018$375.91M-7.0%
2017$404.23M+1.1%
2016$399.85M+328.2%
2015$93.37M+101.3%
2014$46.38M+45.4%
2013$31.89M+44.3%
2012$22.11M+73.7%
2011$12.73M-19.4%
2010$15.79M